Naproxen Azure Pharmaceuticals

naproxen, the active ingredient in Naproxen Azure Pharmaceuticals, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, inflammation, fever and arthritis in adult patients.

GNH USA supplies Naproxen Azure Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen acts on inflammatory pathways to relieve several common conditions. - Pain: provides analgesic relief for mild to moderate musculoskeletal pain. - Inflammation: reduces swelling and redness in acute inflammatory states. - Fever: lowers elevated body temperature associated with inflammatory processes. - Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: dyspepsia, abdominal discomfort. - Nausea or vomiting. - Headache. - Dizziness. - Mild skin rash. - Elevated liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Renal impairment or failure. - Cardiovascular events such as myocardial infarction. - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis). - Hepatic failure. - Anaphylaxis or severe hypersensitivity.

Before initiating therapy, consider the following safety measures. - Assess renal function: avoid or adjust use in patients with significant renal impairment. - Evaluate gastrointestinal risk: use cautiously in individuals with a history of ulcers or bleeding. - Review cardiovascular history: NSAIDs may increase thrombotic risk in susceptible patients. - Monitor hepatic enzymes: discontinue if significant liver injury is detected. - Avoid use in patients with known hypersensitivity to naproxen or other NSAIDs. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Naproxen can affect the activity of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding potential.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal clearance of naproxen. - Corticosteroids: enhanced risk of gastrointestinal ulceration.